Tech Company Financing Transactions
Biolytx Pharmaceuticals Funding Round
i2e Enterprise Oklahoma Fund and private investors participated in a $1.1 million funding round for Biolytx Pharmaceuticals. This venture round was recorded on 11/10/2015.
Transaction Overview
Company Name
Announced On
11/10/2015
Transaction Type
Venture Equity
Amount
$1,100,000
Round
Undisclosed
Investors
i2e Enterprise Oklahoma Fund (Lead Investor)
Proceeds Purpose
Biolytx plans to use the new investment dollars to further pre-clinical studies of its initial peptide for corneal wound healing, said William A. Hagstrom, co-founder and board member.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
800 Research Pkwy.
Oklahoma City, OK 73104
USA
Oklahoma City, OK 73104
USA
Phone
Website
Email Address
Overview
Biolytx Pharmaceuticals, Corp. is a pharmaceutical technology company developed by Dr. Anne Pereira and the University of Oklahoma Health Sciences Center.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Douglas Branch
Chief Scientific Officer
Anne Pereira
Co-Founder
William Hagstrom
Browse more venture capital transactions:
Prev: 11/10/2015: Shelfbucks venture capital transaction
Next: 11/10/2015: ImThera Medical venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs